+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted RNA Sequencing Market - Global Forecast 2026-2032- Product Image
Targeted RNA Sequencing Market - Global Forecast 2026-2032- Product Image
New

Targeted RNA Sequencing Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277865
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Targeted RNA Sequencing: Executive Overview

Targeted RNA sequencing focuses sequencing capacity on selected transcripts, genes, or RNA panels rather than the full transcriptome. This approach supports efficient investigation of defined biological pathways, disease signatures, fusion events, immune-receptor repertoires, and other research or clinical questions. Its value is strongest where users need greater depth, consistent assay design, and manageable analysis workflows for limited or degraded samples.

How Targeted RNA Sequencing Is Reshaping Genomics

The landscape is shifting toward focused assays that combine broad biological relevance with operational efficiency. Researchers and diagnostic developers increasingly emphasize reproducible panel design, compatibility with formalin-fixed or otherwise challenging specimens, streamlined library preparation, and analysis pipelines that can distinguish clinically or biologically meaningful signals from background expression. Adoption is also being shaped by demand for multi-omic integration, standardized quality controls, and workflows that can move from discovery studies toward validation and routine testing.

Artificial Intelligence Accelerates Interpretation and Workflow Design

Artificial intelligence is affecting targeted RNA sequencing primarily through workflow optimization and interpretation. Machine-learning methods can help prioritize transcripts for panel development, identify expression patterns, detect fusion or splicing signals, flag quality concerns, and support classification of samples. Natural-language processing can assist with evidence review and annotation, while automated pipelines reduce manual handling of high-dimensional results. Effective use still depends on representative training data, transparent validation, human oversight, and controls for batch effects, bias, and data privacy.

Regional Insights Across the Global Landscape

North America is characterized by strong translational research activity, advanced sequencing infrastructure, and close interaction between academic, clinical, and biotechnology environments. Europe benefits from coordinated research networks, established genomic medicine programs, and regulatory attention to analytical validity and data governance. Asia-Pacific combines expanding research capacity with substantial population diversity and growing interest in precision medicine. Latin America is developing targeted sequencing capabilities through academic centers, public laboratories, and partnerships, while access, reimbursement, and infrastructure remain important considerations. The Middle East is investing in genomics capacity and specialized healthcare programs, and Africa presents significant research opportunities alongside persistent constraints in laboratory access, bioinformatics resources, and sample logistics.

Group-Level Dynamics: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries are pursuing genomics through varied national strategies, creating opportunities for regional collaboration, shared training, and locally relevant panels. BRICS members bring substantial research populations and scientific capacity but differ in infrastructure, regulation, and data-sharing practices. The European Union emphasizes cross-border research coordination, privacy protection, and interoperability. G7 countries generally have mature sequencing ecosystems and strong translational networks, while NATO members may benefit from cooperation in biomedical preparedness, laboratory resilience, and secure data practices. GCC countries are strengthening centralized healthcare and genomics initiatives, with demand influenced by inherited disease research, population-specific reference data, and clinical integration.

Country Perspectives on Adoption and Capability

The United States and Canada combine advanced research institutions, clinical sequencing programs, and established bioinformatics expertise. The United Kingdom, France, Germany, Italy, and Spain benefit from strong public research systems and European collaboration, with adoption influenced by validation requirements and health-system integration. China, Japan, South Korea, India, and Australia are expanding precision-medicine research, sequencing infrastructure, and computational capacity, while national priorities differ across oncology, inherited disease, infectious disease, and population genomics. Brazil and Mexico are developing capabilities through leading institutions and public-health initiatives, with affordability, workforce development, and regional access remaining central issues. Russia maintains research expertise but faces complex collaboration and procurement conditions that can affect workflow deployment.

Priorities for Leaders Building Durable RNA Sequencing Programs

Industry leaders should begin with clearly defined use cases and select targets based on biological relevance, expected specimen quality, and the intended decision pathway. They should validate analytical sensitivity, specificity, reproducibility, and performance across relevant sample types before expanding applications. Interoperable software, traceable quality controls, secure data handling, and transparent reporting can strengthen user confidence. Regional partnerships and workforce training are especially important where infrastructure is uneven. Leaders should also establish governance for AI-assisted interpretation, monitor model performance over time, and align product development with applicable laboratory, clinical, privacy, and reimbursement requirements.

Methodology for the Executive Assessment

This executive summary uses a qualitative synthesis of the Targeted RNA Sequencing market scope and the specified regional, group, and country coverage. The assessment organizes established drivers, workflow developments, technology implications, and adoption conditions without presenting market estimates, shares, forecasts, or company-specific claims. Regional and country observations are framed around research capacity, healthcare infrastructure, regulatory context, data governance, workforce readiness, and translational potential. Artificial intelligence considerations are limited to documented roles in assay design, analysis, quality control, and interpretation, with emphasis on validation and responsible deployment.

Conclusion: Focused Sequencing Supports More Actionable RNA Insight

Targeted RNA sequencing occupies an important position between broad discovery and practical, repeatable measurement. Its ability to concentrate analytical depth on defined biological questions can improve efficiency, support difficult specimens, and facilitate translation into research and clinical workflows. Progress will depend on robust validation, interoperable analysis, responsible artificial intelligence, equitable infrastructure, and regionally appropriate implementation. Organizations that connect assay design to clearly defined decisions and durable quality systems will be best positioned to realize its value.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Targeted RNA Sequencing Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Sequencers
7.2.2. Target Enrichment Systems
7.3. Kits And Reagents
7.3.1. Consumables
7.3.2. Library Preparation Kits
7.3.3. Quality Control Reagents
7.3.4. Reverse Transcription Kits
7.3.5. Target Enrichment Kits
7.4. Services
7.4.1. Clinical Testing
7.4.1.1. Genetic Disease Testing Services
7.4.1.2. Oncology Testing Services
7.4.2. Contract Sequencing
7.4.3. Research Services
7.5. Software
7.5.1. Data Analysis Software
7.5.2. Laboratory Information Systems
8. Targeted RNA Sequencing Market, by End User
8.1. Introduction
8.2. Academic And Research Institutes
8.3. Clinical Laboratories And Hospitals
8.3.1. Clinical Laboratories
8.3.2. Hospitals
8.4. Contract Research Organizations
8.5. Diagnostic Companies
8.6. Pharmaceuticals And Biotechnology
8.6.1. Large Pharmaceutical Companies
8.6.2. Small And Medium Biotech
9. Targeted RNA Sequencing Market, by Technology
9.1. Introduction
9.2. Amplicon Based
9.3. Hybrid Capture
9.4. Molecular Inversion Probes
9.5. Multiplex PCR
10. Targeted RNA Sequencing Market, by Sample Type
10.1. Introduction
10.2. Blood And Plasma
10.3. Formalin Fixed Paraffin Embedded
10.4. Fresh Frozen
10.5. Saliva
11. Targeted RNA Sequencing Market, by Disease Indication
11.1. Introduction
11.2. Cardiovascular Diseases
11.3. Hematologic Malignancies
11.4. Infectious Diseases
11.5. Neurological Disorders
11.6. Rare Genetic Diseases
11.7. Solid Tumors
12. Targeted RNA Sequencing Market, by Sequencing Platform
12.1. Introduction
12.2. BGI MGI
12.3. Illumina
12.4. Oxford Nanopore
12.5. PacBio
12.6. Thermo Fisher Ion Torrent
13. Targeted RNA Sequencing Market, by Panel And Service Model
13.1. Introduction
13.2. Panel Size
13.2.1. Large Panels (>500 Genes)
13.2.2. Medium Panels (50-500 Genes)
13.2.3. Small Panels (< 50 Genes)
13.3. Service Model
13.3.1. In House Testing
13.3.2. Outsourced Services
14. Targeted RNA Sequencing Market, by Application
14.1. Introduction
14.2. Biomarker Discovery
14.3. Companion Diagnostics
14.4. Drug Discovery And Development
14.5. Genetic Disease Research
14.6. Infectious Disease
14.7. Oncology
15. Targeted RNA Sequencing Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Targeted RNA Sequencing Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Targeted RNA Sequencing Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. 10x Genomics, Inc.
19.2. Agilent Technologies, Inc.
19.3. Berry Genomics
19.4. BGI Genomics
19.5. Bio-Rad Laboratories, Inc.
19.6. DNASTAR, Inc.
19.7. Element Biosciences, Inc.
19.8. F. Hoffmann-La Roche Ltd.
19.9. GATC Biotech AG
19.10. Genomatix GmbH
19.11. Genomic Expression
19.12. Hamilton Company
19.13. HTG Molecular Diagnostics, Inc.
19.14. Illumina, Inc.
19.15. Macrogen, Inc.
19.16. NanoString Technologies, Inc.
19.17. NantOmics, LLC
19.18. Novogene Co., Ltd.
19.19. Oxford Nanopore Technologies plc
19.20. Pacific Biosciences of California, Inc.
19.21. PerkinElmer, Inc.
19.22. QIAGEN N.V.
19.23. RealSeq Biosciences
19.24. Takara Bio Inc.
19.25. Tecan Trading AG
19.26. Thermo Fisher Scientific Inc.
19.27. Twist Bioscience Corporation
19.28. Ultima Genomics, Inc.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Targeted RNA Sequencing Market, Years Considered for the Study
FIGURE 2. Global Targeted RNA Sequencing Market, Research Design
FIGURE 3. Global Targeted RNA Sequencing Market, Research Framework
FIGURE 4. Global Targeted RNA Sequencing Market, Data Triangulation
FIGURE 5. Global Targeted RNA Sequencing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Targeted RNA Sequencing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Targeted RNA Sequencing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Targeted RNA Sequencing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Targeted RNA Sequencing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Targeted RNA Sequencing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Targeted RNA Sequencing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Targeted RNA Sequencing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Targeted RNA Sequencing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Targeted RNA Sequencing Market Size, by Disease Indication, 2025 vs 2032 (%)
FIGURE 15. Global Targeted RNA Sequencing Market Size, by Disease Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Targeted RNA Sequencing Market Size, by Sequencing Platform, 2025 vs 2032 (%)
FIGURE 17. Global Targeted RNA Sequencing Market Size, by Sequencing Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Targeted RNA Sequencing Market Size, by Panel And Service Model, 2025 vs 2032 (%)
FIGURE 19. Global Targeted RNA Sequencing Market Size, by Panel And Service Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Targeted RNA Sequencing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 21. Global Targeted RNA Sequencing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Targeted RNA Sequencing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Targeted RNA Sequencing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Targeted RNA Sequencing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Targeted RNA Sequencing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Targeted RNA Sequencing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Targeted RNA Sequencing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Targeted RNA Sequencing Market Segmentation & Coverage
TABLE 2. Global Targeted RNA Sequencing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Target Enrichment Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Target Enrichment Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Target Enrichment Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Kits And Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Kits And Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Kits And Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Library Preparation Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Library Preparation Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Library Preparation Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Quality Control Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Quality Control Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Quality Control Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Reverse Transcription Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Reverse Transcription Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Reverse Transcription Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Target Enrichment Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Target Enrichment Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Target Enrichment Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Clinical Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Clinical Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Clinical Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Genetic Disease Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Genetic Disease Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Genetic Disease Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Oncology Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Oncology Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Oncology Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Contract Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Contract Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Contract Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Research Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Research Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Research Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Laboratory Information Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Laboratory Information Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Laboratory Information Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Clinical Laboratories And Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Clinical Laboratories And Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Clinical Laboratories And Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Diagnostic Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Diagnostic Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Diagnostic Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Pharmaceuticals And Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Pharmaceuticals And Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Pharmaceuticals And Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Large Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Large Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Large Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Small And Medium Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Small And Medium Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Small And Medium Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 87. Global Amplicon Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Amplicon Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Amplicon Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Hybrid Capture Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hybrid Capture Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hybrid Capture Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Molecular Inversion Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Molecular Inversion Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Molecular Inversion Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Multiplex PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Multiplex PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Multiplex PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 100. Global Blood And Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Blood And Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Blood And Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Formalin Fixed Paraffin Embedded Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Formalin Fixed Paraffin Embedded Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Formalin Fixed Paraffin Embedded Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Fresh Frozen Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Fresh Frozen Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Fresh Frozen Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 113. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Hematologic Malignancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Hematologic Malignancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Hematologic Malignancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Neurological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Neurological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Neurological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Rare Genetic Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Rare Genetic Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Rare Genetic Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Solid Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Solid Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Solid Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 132. Global BGI MGI Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global BGI MGI Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global BGI MGI Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Illumina Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Illumina Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Illumina Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Oxford Nanopore Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Oxford Nanopore Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Oxford Nanopore Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global PacBio Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global PacBio Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global PacBio Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Thermo Fisher Ion Torrent Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Thermo Fisher Ion Torrent Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Thermo Fisher Ion Torrent Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 148. Global Panel Size Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Panel Size Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Panel Size Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Large Panels (>500 Genes) Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Large Panels (>500 Genes) Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Large Panels (>500 Genes) Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Medium Panels (50-500 Genes) Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Medium Panels (50-500 Genes) Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Medium Panels (50-500 Genes) Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Small Panels (< 50 Genes) Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Small Panels (< 50 Genes) Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Small Panels (< 50 Genes) Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Service Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Service Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Service Model Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global In House Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global In House Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global In House Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Outsourced Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Outsourced Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Outsourced Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Drug Discovery And Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Drug Discovery And Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Drug Discovery And Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Genetic Disease Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Genetic Disease Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Genetic Disease Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. Global Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. North America Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. North America Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. North America Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 210. North America Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 211. North America Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 212. North America Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 213. North America Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 214. North America Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. North America Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 216. North America Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 217. North America Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. North America Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 219. North America Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 220. North America Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 221. North America Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 222. North America Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 223. North America Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 224. North America Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Latin America Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 226. Latin America Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Latin America Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 228. Latin America Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 229. Latin America Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 230. Latin America Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 231. Latin America Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 232. Latin America Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Latin America Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 234. Latin America Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 235. Latin America Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. Latin America Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 237. Latin America Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 238. Latin America Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 239. Latin America Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 240. Latin America Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 241. Latin America Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 242. Latin America Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Europe Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Europe Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Europe Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 246. Europe Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 247. Europe Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. Europe Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 249. Europe Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 250. Europe Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Europe Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 252. Europe Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 253. Europe Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 254. Europe Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 255. Europe Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 256. Europe Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 257. Europe Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 258. Europe Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 259. Europe Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 260. Europe Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Middle East Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Middle East Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. Middle East Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 264. Middle East Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 265. Middle East Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 266. Middle East Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 267. Middle East Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 268. Middle East Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Middle East Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 270. Middle East Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 271. Middle East Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. Middle East Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 273. Middle East Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 274. Middle East Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 275. Middle East Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 276. Middle East Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 277. Middle East Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 278. Middle East Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. Africa Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 280. Africa Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. Africa Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 282. Africa Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 283. Africa Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 284. Africa Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 285. Africa Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 286. Africa Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Africa Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 288. Africa Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 289. Africa Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 290. Africa Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 291. Africa Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 292. Africa Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 293. Africa Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 294. Africa Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 295. Africa Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 296. Africa Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. Global Targeted RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 298. ASEAN Targeted RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 299. ASEAN Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 300. ASEAN Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 301. ASEAN Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 302. ASEAN Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 303. ASEAN Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 304. ASEAN Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 305. ASEAN Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. ASEAN Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 307. ASEAN Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 308. ASEAN Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. ASEAN Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 310. ASEAN Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 311. ASEAN Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 312. ASEAN Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 313. ASEAN Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 314. ASEAN Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 315. ASEAN Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. GCC Targeted RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 317. GCC Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 318. GCC Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 319. GCC Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 320. GCC Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 321. GCC Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 322. GCC Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 323. GCC Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. GCC Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 325. GCC Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 326. GCC Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 327. GCC Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 328. GCC Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 329. GCC Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 330. GCC Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 331. GCC Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 332. GCC Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 333. GCC Targeted RNA Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 334. European Union Targeted RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 335. European Union Targeted RNA Sequencing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 336. European Union Targeted RNA Sequencing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 337. European Union Targeted RNA Sequencing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 338. European Union Targeted RNA Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 339. European Union Targeted RNA Sequencing Market Size, by Clinical Testing, 2017-2032 (USD Million)
TABLE 340. European Union Targeted RNA Sequencing Market Size, by Software, 2017-2032 (USD Million)
TABLE 341. European Union Targeted RNA Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 342. European Union Targeted RNA Sequencing Market Size, by Clinical Laboratories And Hospitals, 2017-2032 (USD Million)
TABLE 343. European Union Targeted RNA Sequencing Market Size, by Pharmaceuticals And Biotechnology, 2017-2032 (USD Million)
TABLE 344. European Union Targeted RNA Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 345. European Union Targeted RNA Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 346. European Union Targeted RNA Sequencing Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 347. European Union Targeted RNA Sequencing Market Size, by Sequencing Platform, 2017-2032 (USD Million)
TABLE 348. European Union Targeted RNA Sequencing Market Size, by Panel And Service Model, 2017-2032 (USD Million)
TABLE 349. European Union Targeted RNA Sequencing Market Size, by Panel Size, 2017-2032 (USD Million)
TABLE 350. European Union Targeted RNA Sequencing Market Size, by Service Model, 2017-2032 (USD Million

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Berry Genomics
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • DNASTAR, Inc.
  • Element Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GATC Biotech AG
  • Genomatix GmbH
  • Genomic Expression
  • Hamilton Company
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • NanoString Technologies, Inc.
  • NantOmics, LLC
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • RealSeq Biosciences
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Ultima Genomics, Inc.

Related Topics

Related Reports

miRNA Sequencing & Assay Market - Global Forecast 2026-2032 - Product Image

miRNA Sequencing & Assay Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Targeted Genome Analysis Kits Market - Global Forecast 2026-2032 - Product Image

Targeted Genome Analysis Kits Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
NGS-Based RNA-Sequencing Market - Global Forecast 2026-2032 - Product Image

NGS-Based RNA-Sequencing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Sequencing Reagents Market - Global Forecast 2026-2032 - Product Image

Sequencing Reagents Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
microRNA Market - Global Forecast 2026-2032 - Product Image

microRNA Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.